格列吡嗪的体外促胰岛素分泌能力。 - Suppr

Suppr

超能文献

Insulinotropic potency of glipizide in vitro.

作者信息

Herchuelz A, Malaisse W J

出版信息

Diabetologia. 1973 Sep:309-10. doi: 10.1007/BF01218439.

DOI:10.1007/BF01218439

PMID:4772977

Abstract

摘要

相似文献

Insulinotropic potency of glipizide in vitro.

Diabetologia. 1973 Sep:309-10. doi: 10.1007/BF01218439.

[Glipizide stimulation of insulin production in the pancreas of the anesthetized dog].

Rev Med Liege. 1974 Mar 1;29(5):137-9.

Pharmacodynamic aspects of two sulphonylurea derivatives glipizide and glibenclamide.

Diabetologia. 1973 Sep:311-6. doi: 10.1007/BF01218440.

Insulinotropic action of a new sulfonylurea: gliclazide.

Rev Eur Etud Clin Biol. 1972 Mar;17(3):310-4.

Effect of glipizide on the release of insulin in the perfused rat pancreas in vitro.

Endocrinol Jpn. 1974 Jun;21(3):279-81. doi: 10.1507/endocrj1954.21.279.

Unaltered glucagon secretion after seven days of sulphonylurea administration in normal subjects.

Diabetologia. 1973 Sep:317-9. doi: 10.1007/BF01218441.

[Changes in blood glucose and insulin in 4 normal subjects after administration of a single dose of glipizide and glibenclamide].

Minerva Med. 1974 Jan 6;65(1):58-9.

A clinical study of the metabolic effect of a new oral hypoglycemic agent: glipizide.

Int J Clin Pharmacol. 1974 Apr;7(3):225-31.

Enhancement by succinic acid dimethyl ester of insulin release evoked by D-glucose and glimepiride in the perfused pancreas of normoglycemic and hyperglycemic rats.

Biochem Pharmacol. 1994 Apr 29;47(9):1519-24. doi: 10.1016/0006-2952(94)90526-6.

In vitro insulinotropic action of a new non-sulfonylurea hypoglycemic agent, calcium (2s)-2-benzyl-3-(cis-hexahydro-2-isoindolinyl-carbonyl) propionate dihydrate (KAD-1229), in rat pancreatic B-cells.

Biochem Pharmacol. 1995 Jan 18;49(2):165-71. doi: 10.1016/s0006-2952(94)00484-6.

引用本文的文献

Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.

Drugs. 1981 Oct;22(4):295-320. doi: 10.2165/00003495-198122040-00003.

Glipizide versus tolbutamide, an open trial. Effects on insulin secretory patterns and glucose concentrations.

Diabetologia. 1980 Jan;18(1):49-54. doi: 10.1007/BF01228302.

Binding of hypoglycaemic sulphonylureas to an artificial phospholipid bilayer.

Diabetologia. 1984 Jan;26(1):55-9. doi: 10.1007/BF00252264.

Glipizide, a new oral antidiabetic agent (report of a controlled clinical study in Sweden).

Diabetologia. 1973 Sep:339-47. doi: 10.1007/BF01218444.

The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs.

Clin Pharmacokinet. 1987 Jun;12(6):379-401. doi: 10.2165/00003088-198712060-00001.

Glucose both inhibits and stimulates insulin secretion from isolated pancreatic islets exposed to maximally effective concentrations of sulfonylureas.

Naunyn Schmiedebergs Arch Pharmacol. 1988 Oct;338(4):459-62. doi: 10.1007/BF00172128.

本文引用的文献

A new method for the measurement in vitro of pancreatic insulin secretion.

Endocrinology. 1967 Jan;80(1):99-108. doi: 10.1210/endo-80-1-99.

Effects of glycodiazin and glybenclamide upon insulin secretion in vitro.

Eur J Pharmacol. 1970 Jan;9(1):93-8. doi: 10.1016/0014-2999(70)90325-0.

Insulinotropic effect and possible mode of action of a new potent sulfonylurea (BS-4231).

Can J Physiol Pharmacol. 1971 Jun;49(6):536-44. doi: 10.1139/y71-069.

Insulinotropic action of a new sulfonylurea: gliclazide.

Rev Eur Etud Clin Biol. 1972 Mar;17(3):310-4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验